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OBJECTIVES: This study aimed to assess the impact of the duration of organ dysfunction on the outcome of patients with severe 
sepsis or septic shock.
METHODS: Clinical data were collected from hospital charts of patients with severe sepsis and septic shock admitted to a mixed 
intensive care unit from November 2003 to February 2004. The duration of organ dysfunction prior to diagnosis was correlated 
with mortality. Results were considered significant if p<0.05. 
RESULTS: Fifty-six patients were enrolled. Mean age was 55.6 ± 20.7 years, mean APACHE II score was 20.6 ± 6.9, and mean 
SOFA score was 7.9 ± 3.7. Thirty-six patients (64.3%) had septic shock. The mean duration of organ dysfunction was 1.9 ± 1.9 
days. Within the univariate analysis, the variables correlated with hospital mortality were: age (p=0.015), APACHE II (p=0.008), 
onset outside the intensive care unit (p=0.05), blood glucose control (p=0.05) and duration of organ dysfunction (p=0.0004). In 
the multivariate analysis, only a duration of organ dysfunction persisting longer than 48 hours correlated with mortality (p=0.004, 
OR: 8.73 (2.37-32.14)), whereas the APACHE II score remained only a slightly significant factor (p=0.049, OR: 1.11 (1.00-1.23)). 
Patients who received therapeutic interventions within the first 48 hours after the onset of organ dysfunction exhibited lower mor-
tality (32.1% vs. 82.1%, p=0.0001).
CONCLUSIONS: These findings suggest that the diagnosis of organ dysfunction is not being made in a timely manner. The time 
elapsed between the onset of organ dysfunction and initiation of therapeutic intervention can be quite long, and this represents an 
important determinant of survival in cases of severe sepsis and septic shock.
KEYWORDS: Sepsis diagnosis. Sepsis management. Surviving Sepsis Campaign. Intensive care. Infection.
INTRODUCTION
The incidence of sepsis has increased dramatically over 
the past several decades. A number of factors may have 
played a role in this increase, such as advanced patient age, 
increased numbers of diagnostic and therapeutic procedures, 
frequent use of immunosuppressive drugs, and the growing 
number of multidrug-resistant bacterial infections, especially 
within the nosocomial environment.1 Sepsis is a common 
condition in intensive care units (ICU), affecting about 37% 
of admitted patients.2
In the United States, 215,000 deaths are believed to result 
from severe sepsis annually, a figure that matches the number 
of deaths due to acute myocardial infarction.3 Although the 
disease-associated mortality rate for sepsis is beginning to 
decline, it remains unacceptably high, reaching 30-50% for 
patients with severe sepsis.4 In Brazil, sepsis-related mortality 
rates are also very high, ranging from 34.7% in patients with 
sepsis to 52.2% in patients with septic shock.5 
The social and economic burden associated with the 
disease is just as alarming. According to American data, 
about US$22,000 is spent per septic patient, a figure that 
may be higher for intensive care patients.3 A Brazilian study 
found a mean cost of US$9,632 per ICU patient.6 Moreover, 
severe sepsis and septic shock survivors were described as 
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experiencing a high long-term mortality rate and a significant 
drop in their health-related quality of life.7,8
Encouraging data from recent studies suggest that it 
may be possible to ameliorate this situation.9-13 However, the 
incorporation of new evidence into medical practice is a slow 
process. The Surviving Sepsis Campaign (SCC), sponsored 
by the Society of Critical Care Medicine, the European 
Society of Intensive Care Medicine, and the International 
Sepsis Forum, represents an effort to facilitate a rapid change 
in the standard of care in the management of sepsis based on 
the quality of available published data.14 The severe sepsis 
bundles (SSB) provide the core of the SSC implementation 
phase.15
Unfortunately, in a significant number of patients, the 
diagnosis of severe sepsis is not made at the onset of organ 
dysfunction. Early and accurate detection and an increased 
use of appropriate treatments and procedures will be 
essential if SSC is to achieve its goal of reducing mortality 
from severe sepsis by 25% in five years. This study aimed 
to assess the impact of the duration of organ dysfunction 
(DOD) prior to diagnosis on the mortality of patients with 
severe sepsis and septic shock admitted to the ICU. 
MATERIALS AND METHODS 
Population 
Inpatients in a 16-bed mixed ICU at a Brazilian teaching 
hospital were assessed from November 2003 to February 
2004, and those diagnosed with severe sepsis or septic shock 
during their ICU stay were enrolled. Criteria to define sepsis 
and associated conditions followed those proposed by the 
ACCP/SCCM (American College of Chest Physicians/
Society of Critical Care Medicine).16 The definition of severe 
sepsis was based on the criteria stated in Table 1. All patients 
were prospectively enrolled in a clinical trial that aimed to 
assess the cost of sepsis in Brazil (COSTS).6 Patients under 
the age of 18 years were excluded. The institutional Research 
and Ethics Committee of the institution approved the study. 
Patients or their legal representatives signed the informed 
consent form, agreeing to the data collection.
METHODS
Duration of organ dysfunction was assessed and defined 
as the time elapsed between the chart entry of laboratory 
and/or clinical alterations that could have represented the 
onset of organ dysfunction, as defined in Table 1, and the 
moment that sepsis was diagnosed by the healthcare team. 
The moment of diagnosis was defined as the time at which 
a possible diagnosis of severe sepsis or septic shock was 
entered into the chart, or at which steps were taken to 
treat any organ dysfunction considered secondary to the 
infection. For patients with severe sepsis admitted from the 
Emergency Department, the moment of hospital admission 
was considered the beginning of organ dysfunction. 
Demographic data, severity of illness (APACHE II 
score), organ failure assessment (SOFA score), management 
of severe sepsis, and duration of organ dysfunction (DOD) 
were obtained by either chart analysis or consultation of 
the COSTS study database. Management of severe sepsis 
and septic shock was assessed based on therapeutic and 
diagnostic interventions received in the first 24 hours 
following the moment of diagnosis. Analysis was based 
on the current SSC proposals, according to the six-hour 
and 24-hour sepsis bundles recommendations, following 
local adjustments. The data obtained were correlated with 
mortality. 
Statistical analysis
Initially, a descriptive analysis was carried out. Mortality 
was then analyzed in relation to demographic characteristics, 
severity of illness (APACHE II score), organ dysfunction 
assessment (SOFA score), compliance with the SSB, 
and DOD. The Student’s t-test was used for analysis of 
quantitative variables, the chi-square test for qualitative 
variables. Variables with p-values less than 0.10 were 
included in multivariate analysis by logistic regression. 
Additional analysis was performed in which DOD was 
considered a categorized variable, with patients classified 
in Group 1 when a diagnosis was made or an intervention 
performed within the first 48 hours after the onset of organ 
dysfunction, and in Group 2 when these actions occurred 
after 48 hours. As mortality rates were significantly different 
between these two groups, the groups were compared for 
known risks factors that could have explained the difference 
Table 1 - Criteria for definition of organ dysfunction
Arterial hypotension (SBP <90 mm Hg, MAP <70, or SBP decrease >40 
mm Hg)
Arterial hypoxemia (PaO2/FiO2 <300)
Acute oliguria (urine output <0.5 mL/kg/hr for at least 2 hrs) or creatinine 
> 2.0 mg/dL
Altered mental status (Glasgow coma scale <13)
Thrombocytopenia (platelet count <100,000 cells/mm3)
Hyperbilirubinemia (plasma total bilirubin > 2.0 mg/dL or 35 mmol/L)
Unexpected metabolic acidosis (pH < 7.30 or base excess >5.0 mEq/L)
Coagulation abnormalities (INR >1.5 or aPTT >60 sec)
SBP, systolic blood pressure; MAP, mean arterial pressure; INR, interna-
tional normalization ratio; aPTT, activated partial thromboplastin time.
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in mortality, using Student’s t and chi-square tests. 
Statistical analysis was performed using SPSS software, 
version 15.0 for Windows, and results with p-values less than 
0.05 were considered significant.
RESULTS
Fifty-six patients were enrolled, 29 of whom were male 
(51.8%). The mean age was 55.5 ± 20.8 years, the mean 
APACHE II score at admission was 20.6 ± 6.9, and the 
mean SOFA score at the moment of diagnosis was 7.9 ± 
3.7. Surgical cases represented 53.6% of the sample. Forty 
patients (71.4%) acquired the infection within the hospital 
environment. In most cases (75%), severe sepsis or septic 
shock initially occurred in non-ICU units. Thirty-six patients 
(64.3%) were admitted to the ICU due to a presumed or 
confirmed infectious condition. Baseline characteristics are 
displayed in Table 2.
Regarding the presence of organ dysfunction, 46 patients 
(82.1%) presented with two or more organs affected at the 
time of diagnosis. The mean time elapsed between evidence 
of the onset of dysfunction and the moment of diagnosis 
was 1.9 ± 1.9 days, and 11 patients (19.6%) had experienced 
dysfunction of at least one organ for five days or longer. 
Patients in the ICU had a shorter DOD (1.2 ± 1.3) than 
those coming from other ward units (2.2 ± 2.0), although 
this difference was not statistically significant (p=0.11). 
Among the patients coming from other hospital wards, 
26.7% had experienced organ dysfunction for more than five 
days. Surgical patients also had a longer DOD than medical 
patients, although again, this difference was not statistically 
significant (2.23 ± 2.07 vs. 1.46 ± 1.65, p=0.134).
Overall, mortality was 57.1%. The mortality rate for 
patients with an initial diagnosis of severe sepsis was 
45%, and it was 63.9% for patients diagnosed with septic 
shock (p=0.17). Patients with a longer DOD showed higher 
mortality. As shown in Figure 1, mortality varied from 33.3% 
when intervention was started within the first 24 hours of 
organ dysfunction, to 84.5% when four or more days elapsed 
before treatment was initiated, with a sharp increase after 
48 hours of organ dysfunction. In the univariate analysis, 
variables associated with mortality were: age (p=0.015), 
APACHE II (p=0.008), onset of severe sepsis or septic shock 
outside the ICU (p=0.05), and DOD (p=0.0004) (Table 3). 
Among the diagnostic and therapeutic interventions carried 
out, only blood glucose control was correlated with reduced 
mortality (p=0.05). In contrast, the use of steroids was 
correlated with increased mortality (p=0.05). These variables 
were included in the multivariate analysis. Because there was 
no difference in mortality for patients with a DOD of zero or 
one day (p=0.49), or between patients with a DOD of two, 
three, or four days (p=0.66), this variable was categorized 
as either less than 48 hours or more than 48 hours of organ 
dysfunction. Only a DOD of greater than 48 hours correlated 
with mortality (p=0.004, OR: 8.735 (2.374-32.14)), whereas 
the APACHE II score proved to be a slightly significant 
factor, with p=0.049, OR=1.11 (1.00-1.234).
Twenty-eight patients (50%) underwent therapeutic 
Table 2 - Baseline patient characteristics
Variable All patients
n = 56
Group I
N = 28
Group II
n = 28
p-value*
Age (yrs) 55.6 ± 20.7 50.1 ± 20.8 61.1 ± 19.5 0.05
Gender
Male
Female
29 (51.8%)
27 (48.2%)
17
11
12
16
0.18
APACHE II score 20.6 ± 6.9 19 ± 7.6 22.1 ± 5.7 0.09
SOFA score 7.9 ± 3.7 7.9 ± 3.5 7.9 ± 3.9 0.97
Category
Medical 
Surgical
26 (46.4%)
30 (53.6%)
15
13
11
17
0.28
Patient location 
Hospital ward 
ICU/ED
42 (75%)
14 (25%)
20
8
22
6
0.56
Infectious 
classification
Community-acquired 
Hospital-acquired 
16 (28.6%)
40 (71.4%)
11
17
5
23
0.08
Sepsis classification 
Severe sepsis
Septic shock
20 (35.7%)
36 (64.3%)
8
20
12
16
0.27
Number of organs 
affected 
2.6 ± 1.2 2.75 ± 1.2 2.5 ± 1.2 0.45
Mortality 57.1% 32.1% 82.1% 0.0001
Values are expressed as mean ± standard deviation or number (%); *Chi 
square and Student’s t tests (Group I vs. Group II); ICU, intensive care 
unit; ED, emergency department
Figure 1. Mortality related to duration of organ dysfunction (DOD). DOD 
represents the time elapsed from the onset of organ dysfunction to the time 
of diagnosis in patients with severe sepsis and septic shock. As there was 
no difference in mortality between patients with a DOD of zero or one 
day (p=0.49), or between patients with a DOD of two, three, or four days 
(p=0,66), this variable was grouped as less than 48 hours and more than 48 
hours of organ dysfunction in the multivariate analysis. In this analysis, only 
a DOD of longer than 48 hours was correlated with mortality (p=0.004)
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interventions within the first 48 hours following organ 
dysfunction (Group I), and 28 (50%) had therapeutic 
interventions initiated after 48 hours (Group 2). Mortality 
was significantly higher in Group 2 than in Group 1 (82.1% 
and 32.1%, respectively, p=0.0001). No difference was found 
between the two groups regarding gender, APACHE II score, 
SOFA score, patient category, presence of septic shock, 
or compliance with SSC bundles. There was a significant 
difference in age and antibiotic administration compliance, 
as defined by the SSC six-hour bundle. Patients in Group 
2 were older than those in Group 1 (61.1 ± 19.5 vs. 50.1 
± 20.8, p=0.05), a fact which could have contributed to 
the higher mortality rate. Antibiotic compliance was also 
higher in Group 2 (71.4% vs. 39.3%, p= 0.02) (Table 2 and 
Table 4). 
DISCUSSION
In this study, we were able to show that the time elapsed 
between onset of organ dysfunction and initiation of 
therapeutic intervention can be quite long and that this is an 
important determinant of survival in cases of severe sepsis 
and septic shock.
Our findings suggest that diagnoses are not being made in 
a timely manner. A recent survey found that physicians who 
treat septic patients recognize the difficulty in defining and 
diagnosing sepsis and are aware that they frequently miss 
the diagnosis.17 Assunção et al. compiled 917 questionnaires 
completed in 21 Brazilian public, private, and university 
hospitals that included clinical questions about SIRS, 
infection, sepsis, severe sepsis, and septic shock definitions. 
The authors found that as few as 27.3% of physicians were 
able to identify a case of sepsis, while 56.7% could identify 
a severe sepsis case.18 The heterogeneous presentation of a 
septic patient can render the disease difficult to diagnose, 
especially for non-intensivists and in patients on inpatient 
wards. Recognition of sepsis is a key issue and should be a 
target in educational campaigns. 
Table 3 - Variables associated with mortality in the univari-
ate analysis
Variable All patients
n = 56
Survivors
N = 24
Non-
survivors
n = 32
p-value*
Age (yrs) 55.6 ± 20.7 47.9 ± 18.5 61.3 ± 20.8 0.015
Gender
Male
Female
29 (51.8%)
27 (48.2%)
15
9
14
18
0.19
APACHE II score 20.6 ± 6.9 17.8 ± 7.5 22.6 ± 5.6 0.008
SOFA score 7.9 ± 3.7 7.5 ± 4.1 8.2 ± 3.4 0.52
Category
Medical 
Surgical
26 (46.4%)
30 (53.6%)
13
11
13
19
0.42
Patient location 
Hospital ward 
ICU/ED
42 (75%)
14 (25%)
14
10
28
4
0.015
Infectious 
classification
Community-acquired 
Hospital-acquired 
16 (28.6%)
40 (71.4%)
9
15
7
25
0.16
Sepsis classification 
Severe sepsis
Septic shock
20 (35.7%)
36 (64.3%)
11
13
9
23
0.14
Number of organs 
affected 
2.6 ± 1.2 2.5 ± 1.4 2.7 ± 1.1 0.66
Duration of organ 
dysfunction (days)
1.9 ± 1.9 0.9 ± 1.4 2.6 ± 1.9 0.0001
Values are expressed in mean ± standard deviation or number (%); *Chi 
square and Student’s t tests (survivors vs. non-survivors); APACHE, Acute 
Physiologic and Chronic Health Evaluation; SOFA, Sequential Organ 
Failure Assessment; ICU, intensive care unit; ED, emergency department
Table 4 - Interventions received according to severe sepsis recommendations 
Intervention All patients Group I Group II p-value
Blood cultures 30.4% 25% 35.7% 0.38
Broad-spectrum antibiotics 55.4% 39.3% 71.4% 0.02
Deliver an initial minimum of 20 ml/kg of crystalloid 80.6% 85% 75% 0.45
Vasopressors for hypotension 91.7% 95% 87.5% 0.42
Achieve CVP of > 8 mm Hg 52.8% 45% 62% 0.30
Achieve ScvO2 of > 70% 22.2% 20% 25% 0.72
Low-dose steroids administered for septic shock 30.6% 25% 37.5% 0.42
Blood glucose control 51.8% 53.6% 50% 0.79
Inspiratory plateau pressures maintained < 30 cm H2O 63.6% 55% 70.8% 0.28
24-hour sepsis bundle# 23.2% 17.9% 28.6% 0.18
#No patients received all interventions recommended by the six-hour sepsis bundle; *Chi square test (Group I vs. Group II); CVP, central venous pres-
sure; ScvO2, central venous oxygen saturation
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In this series, the duration of organ dysfunction prior to 
intervention was one of two factors related to mortality in 
a multivariate analysis. Moreover, delayed diagnosis was 
progressively correlated with higher mortality, i.e. the longer 
the organ dysfunction, the higher the patient mortality. The 
risk of death increased 8.73 times for a DOD greater than 
48 hours (IC: 95%, 2.37-2.14). Although this finding may 
seem intuitive, the extent to which a delay in diagnosis and 
intervention can directly impact mortality has not previously 
been clearly demonstrated. 
It should be emphasized that interventions that resulted 
in reduced mortality were all carried out in the early stage 
of sepsis. Therefore, these results further demonstrate the 
importance of early treatment.9,19-22 Previous studies using 
various protocols for hemodynamic optimization failed to 
reduce mortality, potentially because interventions occurred 
in a later phase of the process.23,24 A meta-analysis clearly 
showed that early, and not late, intervention is associated 
with decreased mortality.25 
Another piece of evidence indicating the impact of early 
treatment is the finding that the mortality rate for patients 
diagnosed and treated within the first 24 hours after the 
onset of organ dysfunction was approximately 30%, which 
is similar to the best rates reported in the literature.13 We 
carefully analyzed these groups in order to identify other 
variables that could be responsible for this impressive 
mortality difference. Interestingly, only age and compliance 
with the six-hour SSB bundle regarding antibiotic treatment 
differed between Group 1 (<48 h) and Group 2 (>48 h). No 
other classical risk factors – including gender, number of 
affected organs, number of septic shock patients, category of 
patients, and SOFA and APACHE II scores – were different. 
This suggests that the higher mortality rate observed in 
Group 2 is, indeed, related to the delay in diagnosis. We 
cannot rule out the possibility that patient age influenced 
this result, as the patients in Group 2 were significantly 
older than those in Group 1. However, the age variable 
was not related to mortality in the multivariate analysis of 
this population. Moreover, both variables (age and DOD) 
could be related because the diagnosis of sepsis is often 
more difficult in older patients, as signs of sepsis or organ 
dysfunction can easily be misinterpreted and are often 
attributed to other causes. 
It is also interesting that the antibiotic compliance in 
Group 2 was higher than in Group 1. This higher compliance 
is not easily explained. Clearly, however, it did not contribute 
to lowering the mortality rate. This result was unexpected, 
as compliance was measured from the moment of diagnosis 
and not the onset of organ dysfunction. In this group of 
patients, those moments were quite different, and the concept 
of early antibiotic administration does not apply. The higher 
compliance could be explained by the fact that Group 2 
patients were older and possibly sicker, due to the longer 
DOD. If so, the severity of the infectious process could have 
been more obvious to the health care team at the time the 
diagnosis of sepsis was finally made. However, the small 
number of patients in this group precludes any conclusion 
regarding this finding. 
It should be highlighted that the precise time of onset 
of organ dysfunction is easier to define when reviewing 
retrospective data than it is in clinical practice, even within 
the context of a best practice model, as the first signs of 
organ dysfunction can be attributed to causes other than 
a possible infection. Therefore, in daily bedside practice, 
health care professionals should not be expected to act at the 
precise time at which organ dysfunction begins in every case. 
Given this, our study may have overestimated the duration 
of organ dysfunction. 
Several other limitations must also be mentioned. First, 
this is a retrospective study, and the power of statistical 
analysis was affected by the small number of patients 
enrolled. However, these patients were prospectively 
included in a multicenter sepsis cost study6, and using the 
same casuistic thus prevented missing patients. We also 
believe that the chart data for these patients were quite 
reliable, reducing the negative impact of our retrospective 
assessment. Nonetheless, larger, prospective cohort studies 
will be necessary to confirm the finding that lengthy delays 
often occur in the diagnosis of sepsis and that these delays 
have a significant, negative impact on mortality. 
Second, the mixed nature of our population, including 
both medical and surgical patients, could have influenced 
our findings. These patient populations generally show 
differences in mortality rates. However, it is reasonable to 
assume that the most important fact demonstrated in our 
study – that diagnoses of sepsis are often delayed and that 
this negatively affects mortality – would not be affected by 
the inclusion of surgical patients. Moreover, the duration 
of organ dysfunction was not significantly different in this 
group of patients. 
We also included emergency patients in this study, 
whose duration of organ dysfunction is not always precisely 
known. However, we believe that clinical manifestations of 
organ dysfunction would motivate patients to seek treatment 
immediately in the majority of cases. Given this, the time of 
admission would seem a reasonable definition for the onset 
of organ dysfunction. Even if this assumption is incorrect, 
using this time point as the onset of dysfunction would 
only decrease mean DOD and would therefore potentially 
underestimate any differences seen between the two patient 
groups. It should also be mentioned that only two patients in 
this study were admitted from the ED. 
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Third, when the patients were analyzed by group, the 
higher age in Group 2 could have influenced the power of the 
correlation between DOD and mortality. An additional limit 
to be considered is the fact that most patients did not receive 
the standard recommended treatment, as evidenced by the 
low compliance with the six- and 24-hour bundles. Moreover, 
compliance with the interventions was assessed from the time 
of diagnosis rather than from the onset of organ dysfunction. 
Compliance would have decreased further had the latter 
time point been chosen. However, this does not affect the 
correlation between time of organ dysfunction and mortality. 
Priority must be established to ensure the rapid initiation 
of appropriate interventions in cases of sepsis. Increasing 
early detection of organ dysfunction is the first and most 
fundamental step in achieving this goal. Educational 
programs should address this problem, and strategies 
should be developed to improve medical knowledge about 
diagnosing sepsis.
REFERENCES
1. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of 
sepsis in the United States from 1979 through 2000. N Engl J Med. 
200317;348:1546-54. 
2. Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, et 
al. Sepsis in European intensive care units: results of the SOAP study. 
Crit Care Med. 2006;34:344-53. 
3. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, 
Pinsky MR. Epidemiology of severe sepsis in the United States: analysis 
of incidence, outcome, and associated costs of care. Crit Care Med. 
2001;29:1303-10.
4. Vincent JL, Abraham E, Annane D, Bernard G, Rivers E, Van den Berghe 
G. Reducing mortality in sepsis: new directions. Crit Care. 2002;6 Suppl 
3:S1-18.
5. Silva E, Pedro Mde A, Sogayar AC, Mohovic T, Silva CL, Janiszewski 
M, et al. Brazilian Sepsis Epidemiological Study (BASES study). Crit 
Care. 2004;8:R251-60.
6. Sogayar AMC, Machado FR, Rea-Neto A, Dornas A, Grion C, Lobo 
SM, Tura B, et al. For the Costs Study Group - Latin American Sepsis 
Institute: COSTS – multicenter, prospective study to evaluate costs of 
septic patients in Brazilian intensive care units, Pharmacoeconomics, 
in press.
7. Teres D, Rapoport J, Lemeshow S, Kim S, Akhras K. Effects of severity 
of illness on resource use by survivors and nonsurvivors of severe sepsis 
at intensive care unit admission. Crit Care Med. 2002;30:2413-9.
8. Heyland DK, Hopman W, Coo H, Tranmer J, McColl MA. Long-term 
health-related quality of life in survivors of sepsis. Short Form 36: a 
valid and reliable measure of health-related quality of life. Crit Care 
Med. 2000;28:3599-605.
9. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, et al. 
Early goal-directed therapy in the treatment of severe sepsis and septic 
shock. N Engl J Med. 2001;345:1368-77.
10. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, 
Schetz M, et al. Intensive insulin therapy in the critically ill patients. N 
Engl J Med. 2001;345:1359-67.
11. Ventilation with lower tidal volumes as compared with traditional 
tidal volumes for acute lung injury and the acute respiratory distress 
syndrome. The Acute Respiratory Distress Syndrome Network. N Engl 
J Med. 2000;342:1301-8.
12. Annane D, Sebille V, Charpentier C, Bollaert PE, Francois B, Korach 
JM, et al. Effect of treatment with low doses of hydrocortisone and 
fludrocortisone on mortality in patients with septic shock. Jama. 
2002;288:862-71.
13. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-
Rodriguez A, et al. Efficacy and safety of recombinant human activated 
protein C for severe sepsis. N Engl J Med. 2001;344:699-709.
14. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, et al. 
Surviving Sepsis Campaign: International guidelines for management of 
severe sepsis and septic shock: 2008. Intensive Care Med. 2008;34:17-60.
15. Institute for Healthcare Improvement: Sepsis [http://www.ihi.org/IHI/
Topics/CriticalCare/Sepsis.html].
16. American College of Chest Physicians/Society of Critical Care Medicine 
Consensus Conference: definitions for sepsis and organ failure and 
guidelines for the use of innovative therapies in sepsis. Crit Care Med. 
1992;20:864-74.
17. Poeze M, Ramsay G, Gerlach H, Rubulotta F, Levy M. An international 
sepsis survey: a study of doctors’ knowledge and perception about sepsis. 
Crit Care. 2004;8:R409-13.
18. Assuncao M, Machado F, Akamine N, Cardoso G, Mello P, Telles J, et 
al. Do they know what is sepsis time? Septic Patients Survey Enrolling 
Staffs study. Critical Care. 2007;11(Suppl 2):P45.
19. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, et al. 
Duration of hypotension before initiation of effective antimicrobial 
therapy is the critical determinant of survival in human septic shock. 
Crit Care Med. 2006;34:1589-96.
20. Vincent JL, Bernard GR, Beale R, Doig C, Putensen C, Dhainaut JF, et 
al. Drotrecogin alfa (activated) treatment in severe sepsis from the global 
open-label trial ENHANCE: further evidence for survival and safety and 
implications for early treatment. Crit Care Med. 2005;33:2266-77.
21. Trzeciak S, Dellinger RP, Abate NL, Cowan RM, Stauss M, Kilgannon 
JH, et al. Translating research to clinical practice: a 1-year experience 
with implementing early goal-directed therapy for septic shock in the 
emergency department. Chest. 2006;129:225-32.
22. Jones AE, Focht A, Horton JM, Kline JA. Prospective external validation 
of the clinical effectiveness of an emergency department-based early 
goal-directed therapy protocol for severe sepsis and septic shock. Chest. 
2007;132:425-32.
23.  Gattinoni L, Brazzi L, Pelosi P, Latini R, Tognoni G, Pesenti A, et al. 
A trial of goal-oriented hemodynamic therapy in critically ill patients. 
SvO2 Collaborative Group. N Engl J Med. 1995;333:1025-32.
24. Silva E, Poli de Figueiredo. Sepsis, from bench to bedside. Clinics. 
2008;63:109-20.
25. Kern JW, Shoemaker WC. Meta-analysis of hemodynamic optimization 
in high-risk patients. Crit Care Med. 2002;30:1686-92.
